Fredun Pharmaceuticals Limited has acquired a 26 percent stake in Goodman Vetcare Private Limited, for an undisclosed sum. This is Fredun Pharma’s second acquisition in the animal health and veterinary retail and pet-care market, in less than two weeks.
The acquisition gives Fredun Pharma a foothold into Goodman’s established retail network. Earlier this month, it had acquired USV’s pet-wellness brand Furlicks, for an undisclosed sum.
“Since 1989, Goodman has built strong relationships with pet parents, veterinary professionals and suppliers, supported by a specialised portfolio spanning veterinary medicines, pet food, accessories and allied pet-care products. The business currently operates three stores across Mumbai and Navi Mumbai, including its flagship store in Parel, a 24×7 veterinary profitable veterinary pharmacy and pet-care operation,” a note from Fredun Pharma said.
They added that Goodman had grown its revenue by 30 per cent annually, from ₹14.1 crore in FY24 to ₹23.6 crore in FY26, without the push from venture capital. The brand is targeting ₹40 crore in revenue by FY27 and ₹56 crore by FY28.
The plan is to take it across India with at least eight new stores across three cities, targeting a revenue of ~₹100 crore in revenue by FY31, Fredun Pharma said. Goodman Vetcare also plans to commission a warehouse in the new city during the first half of the year, enabling stronger stock availability as the network expands, it added.
In the FY26, Fredun reported total revenues of ₹639.12 crore, with an EBITDA of ₹94.79 crore and Profit After Tax of ₹33.21 crore.
Fredun Medhora, Managing Director and Chief Financial Offier, Fredun Pharmaceuticals, said that the aim was to create an “integrated pet-health platform in India.”
Vipul Patil, Chief Executive, Goodman Vetcare Pvt Ltd, said, “With plans to open at least two more stores in Mumbai and our first stores outside Maharashtra by the end of 2027, having the right capabilities and infrastructure in place will be critical to scaling Goodman Chemist sustainably. With this association the pace changes now; the way we work doesn’t.”
Vishal Patil, Director, Goodman Vetcare Pvt Ltd, added, “Animals can’t tell us what they need, but their families carry that worry for them, often going from one shop to the next and hearing ‘not available’ again and again. Goodman was built to be the last stop in that search. With Fredun, we want to be the first.”
Fredun Pharma stock at ₹1379, was up over 2 per cent on BSE, on Tuesday at 2.17 pm.
Published on September 22, 2026




